| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |